Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

864 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
Yang S, Niou ZX, Enriquez A, LaMar J, Huang JY, Ling K, Jafar-Nejad P, Gilley J, Coleman MP, Tennessen JM, Rangaraju V, Lu HC. Yang S, et al. Among authors: ling k. Res Sq [Preprint]. 2023 May 19:rs.3.rs-2859584. doi: 10.21203/rs.3.rs-2859584/v1. Res Sq. 2023. Update in: Mol Neurodegener. 2024 Jan 29;19(1):13. doi: 10.1186/s13024-023-00690-9 PMID: 37292715 Free PMC article. Updated. Preprint.
RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice.
Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles JB, Deitch BJ, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz HB, Grubisha MJ, Huang YH, Thomas G. Villar-Pazos S, et al. Among authors: ling k. Res Sq [Preprint]. 2023 Jan 27:rs.3.rs-2440581. doi: 10.21203/rs.3.rs-2440581/v1. Res Sq. 2023. Update in: Nat Commun. 2023 Oct 17;14(1):6547. doi: 10.1038/s41467-023-42176-8 PMID: 36747781 Free PMC article. Updated. Preprint.
Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.
Nguyen TB, Miramontes R, Chillon-Marinas C, Maimon R, Vazquez-Sanchez S, Lau AL, McClure NR, Wu Z, Wang KQ, England WE, Singha M, Stocksdale JT, Heath M, Jang KH, Jung S, Ling K, Jafar-Nejad P, McKnight JI, Ho LN, Dalahmah OA, Faull RLM, Steffan JS, Reidling JC, Jang C, Lee G, Cleveland DW, Lagier-Tourenne C, Spitale RC, Thompson LM. Nguyen TB, et al. Among authors: ling k. Nat Neurosci. 2025 Jan 6. doi: 10.1038/s41593-024-01850-w. Online ahead of print. Nat Neurosci. 2025. PMID: 39762660
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin.
Su Y, Liu L, Lin C, Deng D, Li Y, Huang M, Wang Y, Ling K, Wang H, Chen Q, Huang G. Su Y, et al. Among authors: ling k. Front Pharmacol. 2024 Dec 3;15:1476739. doi: 10.3389/fphar.2024.1476739. eCollection 2024. Front Pharmacol. 2024. PMID: 39691396 Free PMC article. Review.
864 results